The US food and Drug Administration has confirmed Nine dead stemming from a rare cancer that is associated with breast implants.
The extremely rare cancer, called anaplastic large cell lymphoma, affects cells in the immune system and can be found around the breast implant. It can be found in the skin or lymph nodes and is not a type of breast cancer.
“All of the information to date suggests that women with breast implants have a very low but increased risk of developing ALCL compared to women who do not have breast implants,” the FDA reported.
On Tuesday, the FDA issued an update on its understanding of breast implant-associated ALCL cases.
The agency has received 359 reports of possible breast implant-associated cancer cases as of February 1. But the exact number of cases “remains difficult to determine due to significant limitations in world-wide reporting and lack of global implant sales data,” it said.
Breast implants remain incredibly popular. It’s the top cosmetic surgery performed in the US, with 290,467 procedures in 2016, according to the American Society of Plastic Surgeons.
People who are considering getting the surgery should do their research and discuss with their surgeons about the risks and benefits of textured- and smooth-surfaced implants, the FDA advised.
People who have breast implants should monitor their implants for any changes and get routine screenings such as mammograms or MRIs as recommended by their doctors, the agency suggested.